输血依赖、临终关怀服务使用与白血病临终照护质量
基于监测、流行病学和最终结果-医疗保险数据库,选取2001-2011年死亡的急性和慢性白血病医疗保险受益人,分析输血依赖与临终关怀入组及住院时长等终点的关联。结果显示,输血依赖与临终关怀使用率较高相关(RR 1.08),但与临终关怀住院时长缩短51%相关(RR 0.49)。
要点
- 在21033例白血病患者中,20%在死亡或临终关怀入组前存在输血依赖。
- 临终关怀使用率从2001年的35%上升至2011年的49%。
- 输血依赖患者临终关怀中位时长6天,短于非输血依赖患者的11天(P < .001)。
核心结论
- 输血依赖患者临终关怀使用相对增加但住院时长明显缩短,提示其临终关怀需求高且未完全满足,并存在及时转诊的障碍。
研究设计与样本
- 基于监测、流行病学和最终结果-医疗保险数据库的回顾性队列研究,纳入2001-2011年死亡的急性和慢性白血病医疗保险受益人共21033例,中位年龄79岁。
主要发现
- 20%的患者在死亡或临终关怀入组前存在输血依赖。
- 临终关怀使用率从2001年的35%上升至2011年的49%。
- 临终关怀中位时长为9天,输血依赖患者为6天,非输血依赖患者为11天(P < .001)。
- 调整基线特征后,输血依赖与临终关怀使用率较高相关(RR 1.08;95%CI 1.04-1.12),但与临终关怀住院时长缩短51%相关(RR 0.49;95%CI 0.44-0.54)。
- 无论输血依赖状态如何,临终关怀入组者住院死亡和化疗使用的可能性较低,临终医疗保险中位支出较低。
关键数值与推荐
- 输血依赖定义为死亡或临终关怀入组前30天内至少2次输血。
临床怎么用
- 作者认为,支持姑息性输血的政策方案可能最大化临终关怀对白血病患者的益处。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hospice provides high-quality end-of-life care, but patients with leukemias use hospice services less frequently than those with solid tumors. Transfusion dependence (TD) may hinder or delay enrollment, because hospice organizations typically disallow transfusions. We examined the association between TD and end-of-life outcomes among Medicare beneficiaries with leukemia. From the Surveillance, Epidemiology, and End Results-Medicare database, we selected beneficiaries with acute and chronic leukemias who died in 2001-2011. We defined TD as ≥2 transfusions within 30 days before death or hospice enrollment. End points included hospice enrollment and length of stay, reporting relative risk (RR) adjusted for key covariates. Among 21 033 patients with a median age of 79 years, 20% were transfusion dependent before death/hospice enrollment. Use of hospice increased from 35% in 2001 to 49% in 2011. Median time on hospice was 9 days and was shorter for transfusion-dependent patients (6 vs 11 days; P < .001). Adjusting for baseline characteristics, TD was associated with a higher use of hospice services (RR, 1.08; 95% confidence interval [CI], 1.04-1.12) but also with 51% shorter hospice length of stay (RR, 0.49; 95% CI, 0.44-0.54). Hospice enrollees had a lower likelihood of inpatient death and chemotherapy use and lower median Medicare spending at end-of-life, regardless of TD status. In conclusion, relatively increased hospice use combined with a markedly shorter length of stay among transfusion-dependent patients suggests that they have a high and incompletely met need for hospice services and that they experience a barrier to timely referral. Policy solutions supporting palliative transfusions may maximize the benefits of hospice for leukemia patients.
引用
- LeBlanc TW, Egan PC, Olszewski AJ, et al. Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia. Blood. 2018. PMID: 29848484. doi:10.1182/blood-2018-03-842575
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。